Inso Bio
Next generation DNA sample preparation
United States · Founded 2018 · $2.2M raised
- Employees
- 1–10
- Founded
- 2018
- Website
- inso.bio
- Total Funding
- $2.2M
- Last Round
- $2.2M Pre-SeedMar 2022
- Rounds
- 1
About
Inso Biosciences is a Cornell University-originated biotech company developing a microfluidic DNA sample preparation platform for next-generation sequencing. The company's patented 'micropillar' technology physically captures and purifies high molecular weight DNA directly from blood or cell samples in as little as 10 minutes, eliminating the degradation caused by conventional bead- or column-based approaches. The system enables ultra-long DNA fragment sizes (50 kb to 1,000+ kb), lossless RNA and DNA multiomic extractions, and automated workflows compatible with any downstream sequencer. Inso Biosciences is backed by NY Ventures and several academic and institutional investors.
Summary
Inso Bio is a company based in United States, founded in 2018. It has raised $2.2M in total across 1 round, most recently a $2.2M Pre-Seed round in Mar 2022. Investors include 2048 Ventures.
Sign up to view the funding chart
Create a free account — 25 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Mar 2022